Who invested in Peloton Therapeutics?
Peloton Therapeutics's investors include OrbiMed, RA Capital Management, Foresite Capital, The Column Group and Remeditex Ventures.

United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$190Mraised across 3 rounds since 2011, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $2.0M sold, first sale Jun 2011
From the SEC filings it signed: 2 on the team.
On the board, as filediBrett RingleDavid GoeddelJohn CreecyMichael Brown
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Peloton Therapeutics's investors include OrbiMed, RA Capital Management, Foresite Capital, The Column Group and Remeditex Ventures.
Peloton Therapeutics has raised $190M across 3 rounds since 2011.
Peloton Therapeutics's most recent round was a Series E of $150M in Feb 2019.
Its most recent round, $150M in Feb 2019, is also its largest on record.
Peloton Therapeutics's first round on record, in Jul 2011, was backed by The Column Group and Remeditex Ventures.
Peloton Therapeutics's latest named round is a Series E, in Feb 2019.
Peloton Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.